Super-enhancer hypermutation alters oncogene expression in B cell lymphoma-Reference-Cited by-同舟云学术

Super-enhancer hypermutation alters oncogene expression in B cell lymphoma

Published:2022-07-06 Issue:7920 Volume:607 Page:808-815
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Bal Elodie,Kumar Rahul^ORCID,Hadigol Mohammad,Holmes Antony B.^ORCID,Hilton Laura K.^ORCID,Loh Jui Wan,Dreval Kostiantyn,Wong Jasper C. H.,Vlasevska Sofija,Corinaldesi Clarissa,Soni Rajesh Kumar,Basso Katia,Morin Ryan D.^ORCID,Khiabanian Hossein,Pasqualucci Laura^ORCID,Dalla-Favera Riccardo^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-022-04906-8.pdf

Reference83 articles.

1. Pasqualucci, L. et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat. Genet. 43, 830–837 (2011).

2. Morin, R. D. et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476, 298–303 (2011).

3. Reddy, A. et al. Genetic and functional drivers of diffuse large B cell lymphoma. Cell 171, 481–494 (2017).

4. Chapuy, B. et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat. Med. 24, 679–690 (2018).

5. Schmitz, R. et al. Genetics and pathogenesis of diffuse large B-cell lymphoma. New Engl. J. Med. 378, 1396–1407 (2018).

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MEF2B C-terminal mutations enhance transcriptional activity and stability to drive B cell lymphomagenesis;Nature Communications;2024-08-21

2. Decoding critical targets and signaling pathways in EBV-mediated diseases using large language models;2024-08-07

3. Motive and opportunity: MYC rearrangements in high-grade B-cell lymphoma with MYC and BCL2 rearrangements (an LLMPP study);Blood;2024-08-01

4. Predicting regulatory mutations and their target genes by new computational integrative analysis: A study of follicular lymphoma;Computers in Biology and Medicine;2024-08

5. IRF8-mutant B cell lymphoma evades immunity through a CD74-dependent deregulation of antigen processing and presentation in MHCII complexes;Science Advances;2024-07-12